Viemed Healthcare, Inc. (VMD) Reports In-Line Q2 EPS

Viemed Healthcare, Inc. (NASDAQ: VMD) reported Q2 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $43.3 million versus the consensus estimate of $40.83 million.

For earnings history and earnings-related data on Viemed Healthcare, Inc. (VMD) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Tenon Medical (TNON) Misses Q2 EPS by 395c
• Calamp Corp. (CAMP) Misses Q2 EPS by 33c